Zobrazeno 1 - 10
of 201
pro vyhledávání: '"Richard M, Steingart"'
Autor:
Anthony F. Yu, MD, MS, Charlie White, PhD, Zhigang Zhang, PhD, Jennifer E. Liu, MD, Erin F. Gillespie, MD, Beryl McCormick, MD, Atif J. Khan, MD, Richard M. Steingart, MD, Simon N. Powell, MD, PhD, Oren Cahlon, MD, Lior Z. Braunstein, MD
Publikováno v:
Advances in Radiation Oncology, Vol 9, Iss 10, Pp 101581- (2024)
Purpose: Regional nodal irradiation (RNI) for breast cancer yields improvements in disease outcomes, yet comprehensive target coverage often increases cardiac radiation therapy (RT) dose. Volumetric modulated arc therapy (VMAT) may mitigate high-dose
Externí odkaz:
https://doaj.org/article/1773f058d6274c2caa34de781fff0943
Autor:
Anthony F. Yu, Chau T. Dang, Justine Jorgensen, Chaya S. Moskowitz, Patricia DeFusco, Eric Oligino, Kevin C. Oeffinger, Jennifer E. Liu, Richard M. Steingart
Publikováno v:
Cardio-Oncology, Vol 9, Iss 1, Pp 1-6 (2023)
Abstract Background Echocardiograms are recommended every 3 months in patients receiving human epidermal growth factor 2 (HER2)-targeted therapy for surveillance of left ventricular ejection fraction (LVEF). Efforts to tailor treatment for HER2-posit
Externí odkaz:
https://doaj.org/article/de848bdfc40e4f2097621af902c0a542
Autor:
Anthony F. Yu, I‐Hsin Lin, Justine Jorgensen, Robert Copeland‐Halperin, Stephanie Feldman, Ishmam Ibtida, Amare Assefa, Michelle N. Johnson, Chau T. Dang, Jennifer E. Liu, Richard M. Steingart
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 19 (2023)
Background Cancer therapy–related cardiac dysfunction (CTRCD) is an important treatment‐limiting toxicity for patients with human epidermal growth factor receptor 2 (HER2)–positive breast cancer that adversely affects cancer and cardiovascular
Externí odkaz:
https://doaj.org/article/edcd3fe40d4d49c58c412093a6d13af0
Autor:
Anthony F. Yu, MD, Chaya S. Moskowitz, PhD, Katherine Lee Chuy, MD, Ji Yang, MD, Chau T. Dang, MD, Jennifer E. Liu, MD, Kevin C. Oeffinger, MD, Richard M. Steingart, MD
Publikováno v:
JACC. CardioOncology, Vol 2, Iss 2, Pp 166-175 (2020)
Background: Guidelines recommend left ventricular ejection fraction (LVEF) assessments every 3 months for cardiotoxicity monitoring during human epidermal growth factor receptor 2 (HER2) targeted therapy. Evidence in support of this practice is lacki
Externí odkaz:
https://doaj.org/article/718f7b62478341409f1af3fdaaba9c1b
Autor:
Katherine Lee Chuy, MD, Esther Drill, DrPH, Ji Can Yang, DO, Heather Landau, MD, Hani Hassoun, MD, Omar Nahhas, MD, Carol L. Chen, MD, Anthony F. Yu, MD, Richard M. Steingart, MD, Jennifer E. Liu, MD
Publikováno v:
JACC. CardioOncology, Vol 2, Iss 2, Pp 223-231 (2020)
Background: Advanced light-chain (AL) amyloidosis is associated with poor prognosis, with a 5-year survival rate of
Externí odkaz:
https://doaj.org/article/4b6a6a7484844516bfee702fa0236db7
Publikováno v:
JACC. CardioOncology, Vol 1, Iss 1, Pp 11-13 (2019)
Externí odkaz:
https://doaj.org/article/c81d004acde740f796504e68ce14d0ce
Autor:
Anthony F. Yu, Zachary R. Moore, Chaya S. Moskowitz, Jennifer E. Liu, Chau T. Dang, Lakshmi Ramanathan, Kevin C. Oeffinger, Richard M. Steingart, Adam M. Schmitt
Publikováno v:
JAMA Cardiology.
ImportanceCancer therapy–related cardiac dysfunction (CTRCD) is a potentially serious cardiotoxicity of treatments for ERBB2-positive breast cancer (formerly HER2). Identifying early biomarkers of cardiotoxicity could facilitate an individualized a
Autor:
Syed S Mahmood, Peter A Riedell, Stephanie Feldman, Gina George, Stephen A Sansoterra, Thomas Althaus, Mahin Rehman, Elena Mead, Jennifer E Liu, Richard B Devereux, Jonathan W Weinsaft, Jiwon Kim, Lauren Balkan, Tarek Barbar, Katherine Lee Chuy, Bhisham Harchandani, Miguel-Angel Perales, Mark B Geyer, Jae H Park, M Lia Palomba, Roni Shouval, Ana A Tomas, Gunjan L Shah, Eric H Yang, Daria L Gaut, Michael V Rothberg, Evelyn M Horn, John P Leonard, Koen Van Besien, Matthew J Frigault, Zhengming Chen, Bhoomi Mehrotra, Tomas G Neilan, Richard M Steingart
Publikováno v:
European Heart Journal.
Aims Chimeric antigen receptor T-cell therapy (CAR-T) harnesses a patient’s immune system to target cancer. There are sparse existing data characterizing death outcomes after CAR-T-related cardiotoxicity. This study examines the association between
Autor:
Anthony F. Yu, Richard M. Steingart
Publikováno v:
Journal of the American College of Cardiology. 80:33-35
Autor:
Ioanna Kosmidou, Megan M. Durkin, Eileen Vella, Maria G. Gerew, Sofia Romero, Rosalyn Gamboa, Neisha A. Dejesus, Richard M. Steingart
Publikováno v:
Journal of the American College of Cardiology. 81:2365